Related Experiment Video
Updated: Feb 7, 2026

Using Brain Activation nir-HEG/Q-EEG and Execution Measures CPTs in a ADHD Assessment Protocol
Published on: April 1, 2018
Treatment patterns among adults with ADHD receiving long-acting therapy
Zhou Zhou1, Zheng-Yi Zhou, Sneha S Kellar
1Analysis Group, Inc, 111 Huntington Ave, Fl 14, Boston, MA 02199.
Long-acting (LA) combination therapy for attention-deficit/hyperactivity disorder (ADHD) in adults showed lower adherence and persistence compared to monotherapy. This study highlights potential challenges in ADHD treatment adherence for combination therapy patients.
Area of Science:
- Pharmacology
- Clinical Pharmacy
- Neuroscience
Background:
- Attention-deficit/hyperactivity disorder (ADHD) is a prevalent neurodevelopmental disorder impacting adults.
- Long-acting (LA) medications are a cornerstone of ADHD management.
- Treatment strategies include monotherapy and combination therapy (CT).
Purpose of the Study:
- To compare treatment patterns, adherence, and persistence between LA combination therapy and LA monotherapy in US adults with ADHD.
- To identify differences in medication adherence and persistence based on treatment modality.
Main Methods:
- Retrospective analysis of a large claims database (MarketScan) from April 2009 to March 2014.
- Identification of adult patients with ADHD receiving LA medications, categorizing them into CT or monotherapy based on medication overlap.
- Adherence measured by Proportion of Days Covered (PDC ≥ 0.8) and persistence by Time to Discontinuation (TTD ≥ 30-day gap) within one year post-initiation.
Main Results:
- Out of 225,600 patients, 7.3% received LA CT and 92.7% received LA monotherapy.
- LA CT was associated with significantly lower adherence (7% vs 16%; adjusted OR, 0.38; P < .001) and persistence (median TTD 59 vs 79 days; adjusted HR, 1.32; P < .001) compared to LA monotherapy.
- Mean PDC was lower for CT (0.33) versus monotherapy (0.41).
Conclusions:
- In US adults with ADHD treated with LA medications, LA combination therapy demonstrated significantly lower adherence and persistence than LA monotherapy.
- These findings suggest potential challenges in maintaining consistent treatment with LA combination therapy for ADHD.
- Further research may explore reasons for reduced adherence and persistence in ADHD combination therapy regimens.
More Related Videos
Related Concept Videos
Forces Acting on Chromosomes
Microtubules and motor proteins exert two types of forces on...
Receiver Operating Characteristic Plot
Gene Therapy
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Fixed Action Patterns
Direct-Acting Cholinergic Agonists: Pharmacokinetics

